Published in Minerva Med on November 30, 1987
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev (2002) 2.15
A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol (1974) 1.91
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease. Cancer J Sci Am (2000) 1.42
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol (1985) 1.36
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci (2001) 1.27
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids. Exp Neurol (2001) 1.25
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J Pharmacol Exp Ther (1984) 1.22
Carrier-mediated release of neurotransmitters. Trends Neurosci (1993) 1.22
Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol (1977) 1.21
Does laparoscopic excision of endometriotic ovarian cysts significantly affect ovarian reserve? Insights from IVF cycles. Hum Reprod (2003) 1.21
Multiple GABAB receptors. Trends Pharmacol Sci (1993) 1.21
Synaptosomes still viable after 25 years of superfusion. Neurochem Res (2000) 1.13
Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther (1979) 1.07
Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis (1993) 1.06
CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex. Eur J Pharmacol (1993) 1.05
Detectability of high and low affinity uptake systems for GABA and glutamate in rat brain slices and synaptosomes. Life Sci I (1973) 1.03
Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol (1986) 1.03
In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol (1999) 1.03
Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes. J Pharm Pharmacol (1976) 1.03
Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur J Neurosci (1998) 1.03
Release and exchange studies relating to the synaptosomal uptake of GABA. J Neurochem (1975) 1.02
Testicular dysfunction in Hodgkin's disease before and after treatment. Eur J Cancer (1991) 1.01
Anthropometric indicators and response to gonadotrophin for ovulation induction. Hum Reprod (1994) 1.00
Serotonin release is modulated by presynaptic autoreceptors. Eur J Pharmacol (1979) 0.98
Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers. Neuropharmacology (1988) 0.97
Exchange of neurotransmitter amino acid at nerve endings can simulate high affinity uptake. Nature (1974) 0.96
Functional evidence for multiple gamma-aminobutyric acidB receptor subtypes in the rat cerebral cortex. J Pharmacol Exp Ther (1992) 0.96
Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther (1984) 0.95
Pharmacologically distinct GABAB receptors that mediate inhibition of GABA and glutamate release in human neocortex. Br J Pharmacol (1997) 0.95
Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther (1989) 0.94
d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol (1975) 0.94
Molecular MR imaging for the evaluation of the effect of dynamic stabilization on lumbar intervertebral discs. Eur Spine J (2009) 0.94
Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol (1990) 0.93
d-amphetamine and the release of 3H-norepinephrine from synaptosomes. Eur J Pharmacol (1974) 0.93
N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther (1992) 0.91
Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens. Br J Pharmacol (1991) 0.91
In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem (2002) 0.91
Studies on [3H]GABA and endogenous GABA release in rat cerebral cortex suggest the presence of autoreceptors of the GABAB type. Eur J Pharmacol (1987) 0.90
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. Br J Pharmacol (2006) 0.90
Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol (1995) 0.89
GABA(B) receptor antagonists elevate both mRNA and protein levels of the neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) but not neurotrophin-3 (NT-3) in brain and spinal cord of rats. Neuropharmacology (2000) 0.89
Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.89
Reliability of ovulation tests in infertile women. Obstet Gynecol (2001) 0.89
On the presence in the cerebral cortex of muscarinic receptor subtypes which differ in neuronal localization, function and pharmacological properties. J Pharmacol Exp Ther (1985) 0.89
Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes. Neurosci Lett (1989) 0.89
MR imaging of the knee in patients with medial unicompartmental arthroplasty: comparison among sequences at 1.5 T. Radiol Med (2009) 0.88
Presynaptic alpha 2-adrenoceptors mediating inhibition of noradrenaline and 5-hydroxytryptamine release in rat cerebral cortex: further characterization as different alpha 2-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.88
Evidence for functional native NMDA receptors activated by glycine or D-serine alone in the absence of glutamatergic coagonist. Eur J Neurosci (1998) 0.87
Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens. Arch Toxicol Suppl (1984) 0.87
Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h 5-HT1D receptors. Br J Pharmacol (1998) 0.87
Regional differences in the synaptosomal uptake of 3H-gamma-aminobutyric acid and 14C-glutamate and possible role of exchange processes. J Pharmacol Exp Ther (1974) 0.87
Studies on dopamine uptake and release in synaptosomes. Adv Biochem Psychopharmacol (1978) 0.87
gamma-Aminobutyric acid (GABA) autoreceptors in rat cerebral cortex and spinal cord represent pharmacologically distinct subtypes of the GABAB receptor. J Pharmacol Exp Ther (1993) 0.87
Effects of 26-aminocholesterol, 27-hydroxycholesterol, and 25-hydroxycholesterol on proliferation and cholesterol homeostasis in arterial myocytes. Arterioscler Thromb Vasc Biol (1995) 0.86
Alpha 2-adrenoceptors in rat hypothalamus and cerebral cortex: functional evidence for pharmacologically distinct subpopulations. Eur J Pharmacol (1985) 0.86
Parthenogenetic activation: biology and applications in the ART laboratory. Placenta (2008) 0.86
Phaclofen antagonizes GABA at autoreceptors regulating release in rat cerebral cortex. Eur J Pharmacol (1988) 0.86
Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br J Pharmacol (1998) 0.86
A reevaluation of veratridine as a tool for studying the depolarization-induced release of neurotransmitters from nerve endings. Neurochem Res (1980) 0.86
Effect of the new calcium antagonist lercanidipine and its enantiomers on the migration and proliferation of arterial myocytes. J Cardiovasc Pharmacol (1996) 0.86
Characterization of the GABA autoreceptor in human neocortex as a pharmacological subtype of the GABAB receptor. Eur J Pharmacol (1994) 0.85
Differential antagonism by dicyclomine, pirenzepine and secoverine at muscarinic receptor subtypes in the rat frontal cortex. Eur J Pharmacol (1985) 0.85
GABA and glutamate uptake by subcellular fractions enriched in synaptosomes: critical evaluation of some methodological aspects. Brain Res (1973) 0.85
Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J Neurosci (1994) 0.85
Effect of desmethylimipramine on the release of (3H)norepinephrine induced by various agents in hypothalamic synaptosomes. Mol Pharmacol (1977) 0.85
(-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain. Neuropharmacology (1987) 0.84
Functional interactions between presynaptic NMDA receptors and metabotropic glutamate receptors co-expressed on rat and human noradrenergic terminals. Br J Pharmacol (2007) 0.84
GABAergic nerve terminals in rat hippocampus possess alpha 2-adrenoceptors regulating GABA release. Neurosci Lett (1987) 0.84
Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex. J Neurochem (1993) 0.84
Synaptosomal transport processes. Int Rev Neurobiol (1976) 0.83
Deep brain stimulation in Parkinson's disease patients: biochemical evidence. J Neural Transm Suppl (2006) 0.83
Differential pharmacology and function of two 5-HT1 receptors modulating transmitter release in rat cerebellum. J Pharmacol Exp Ther (1986) 0.83
In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway. Br J Pharmacol (1996) 0.83
Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity. Neuroscience (1993) 0.83
Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release. J Pharmacol Exp Ther (1983) 0.83
Presynaptic muscarinic receptors increase striatal dopamine release evoked by "quashi-physiological" depolarization. Eur J Pharmacol (1982) 0.82
Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. J Pharmacol Exp Ther (1993) 0.82
Can the MRI signal of aggressive fibromatosis be used to predict its behavior? Eur J Radiol (2008) 0.82
Abnormal uterine bleeding associated with iron-deficiency anemia. Etiology and role of hysteroscopy. J Reprod Med (1993) 0.82
Release-regulating presynaptic heterocarriers. Prog Neurobiol (1994) 0.82
Gp120 can revert antagonism at the glycine site of NMDA receptors mediating GABA release from cultured hippocampal neurons. J Neurosci Res (1997) 0.82
Renal transplantation in Alport's syndrome. Personal experience in twelve patients. Contrib Nephrol (1990) 0.82
Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.82
In vivo microdialysis study of GABA(A) and GABA(B) receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus. Neuropharmacology (1997) 0.82
Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis. Eur J Neurosci (1995) 0.82
The "kynurenate test", a biochemical assay for putative cognition enhancers. J Pharmacol Exp Ther (1997) 0.81
The human immunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience (1998) 0.81
Endothelial integrins and their role in maintaining the integrity of the vessel wall. Kidney Int (1993) 0.81
Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur J Pharmacol (1993) 0.81
Human brain N-methyl-D-aspartate receptors regulating noradrenaline release are positively modulated by HIV-1 coat protein gp120. AIDS (1996) 0.81
Release-regulating autoreceptors of the GABAB-type in human cerebral cortex. Br J Pharmacol (1989) 0.81
Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype. Eur J Neurosci (1999) 0.81
Chronic drug treatments induce changes in the sensitivity of presynaptic autoreceptors but not of presynaptic heteroreceptors. Eur J Pharmacol (1983) 0.81
GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels. J Neurosci Res (1999) 0.81
The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release. Eur J Neurosci (2000) 0.81
Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes. Mol Pharmacol (1994) 0.81
Do presynaptic autoreceptors control dopamine release? Nature (1978) 0.81
Color Doppler imaging study in patients with primary open-angle glaucoma treated with timolol 0.5% and carteolol 2%. Eur J Ophthalmol (2001) 0.80
5-Hydroxytryptamine3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J Neurochem (1992) 0.80